Commercialization phase funding for Michigan-based life sciences ventures.
The Biosciences Research and Commercialization Center provides startup and gap funding to promising Michigan-based life sciences and medical device ventures entering the commercialization phase of development. Our customers include entrepreneurs, scientists, corporations, and University Technology Transfer offices.
27
Active Companies
20
Successful Exited Companies
$19.6M
Dollars Invested
$100-250K
Investment Range
Established in 2003 by the Michigan Legislature, the BRCC is located on Western Michigan University’s Parkview Campus and is perfectly positioned to access the wealth of scientific talent and pharmaceutical commercialization expertise that is part of Kalamazoo’s heritage.
Life Sciences Focused
Michigan Based
Return on Investment and
Economic Development
Early Development Through
Commercialization Phase
Long-time home to such industry giants as the Upjohn Co., Richard-Allan Scientific, Stryker Corp. and Pfizer Inc., Kalamazoo offers a forward-looking, entrepreneurial business climate and a growing reputation among venture capitalists seeking to invest in life sciences discoveries and promising business ventures.